CityUHK achieves a historic 4th place in QS Asia University Rankings 2027, debuts in Asia's top five; tops Asia in three indicators and Hong Kong in eight

HONG KONG, Nov. 3, 2026 /PRNewswire/ — City University of Hong Kong…

PAQ Therapeutics to Present First Clinical Data for PT0253, a Selective KRAS G12D Degrader, in Late-Breaking Oral Presentation at the 2026 EORTC-NCI-AACR Symposium

Presentation to highlight the initial safety profile and antitumor activity of PT0253…

STAK Inc. Announces Changes in Management

CHANGZHOU, China, Nov. 3, 2026 /PRNewswire/ — STAK Inc. (the "Company") (Nasdaq:…

Epic Seven's New Server "Foundry" Goes Live to Celebrate Official Steam Launch

Official Steam Launch on Oct 29, Long-term positive synergy anticipated from a…

Creality K3 Now Available at $849, Making Multi-Color 3D Printing More Practical

Creality‘s four-nozzle flagship moves from pre-order to official U.S. availability, bringing faster…

QS Asia Rankings 2027

Hong Kong SAR leads as China rises while India and Singapore face…

World Laureates Forum 2026 Opens with Award Ceremony of the WLF Prize and Main Forum—-Leading Scientists Explore "Break Through for the Next Decade"

SHANGHAI, Nov. 3, 2026 /PRNewswire/ —  A news report from YICAI: On…

LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization

LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel…